|
|
|
|
|
|
Research at WEHI
Updated 09:24:41, 01/08/2006
Profile of the Institute
The Walter and Eliza Hall Institute (WEHI) is one of Australia's foremost medical research establishments, its mission being "mastery of disease through discovery". Over many decades, advances and discoveries at the Institute have led to significant benefits for patients throughout the world.
WEHI scientists are attempting to understand the underlying causes of many diseases, in order to develop better treatments. Prime targets include cancer (leukemia, lymphoma and breast cancer), autoimmune diseases (juvenile diabetes and rheumatoid arthritis), infectious diseases (malaria, leishmaniasis and influenza) and multiple sclerosis.
The Institute's rich history, international reputation for excellence, vibrant intellectual life and state-of-the-art technology attracts many talented graduate and postgraduate researchers to join its ~550-strong staff.
The Institute's main laboratories are sited in a striking modern building at Parkville, 2 km north of Melbourne's central business district, with additional facilities in the adjacent Royal Melbourne Hospital. In addition, a Biotechnology Centre was recently established at La Trobe University's R&D Park at Bundoora, to facilitate commercial development of IP by incubating start-up biotechnology companies.
Resources
High-tech resources include the Joint ProteomicS Laboratory (JPSL), jointly established and supported by WEHI and the Ludwig Institute for Cancer Research; the Australian Genome Research Facility (AGRF), which offers high throughput DNA sequencing and genotyping; superb facilities for mouse genetics; and centralised services for flow cytometry and hybridoma production.
|
|
|
| |
|
|
